Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four key proteins that affect the development of a specific hair type in Yangtze River Delta white goats.

CaV1.2 helps activate hair follicle stem cells without calcium flux.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Keratin peptide signatures in hair may help identify gender and ethnicity.

MK-386 lowers DHT in blood and skin but not in semen.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.

Finasteride may help reduce COVID-19 infection by altering a key gene.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.